New Results
Dosage Matters: A Randomized Controlled Trial of Rehabilitation Dose in the Chronic Phase after Stroke
View ORCID ProfileCarolee Winstein, Bokkyu Kim, Sujin Kim, Clarisa Martinez, View ORCID ProfileNicolas Schweighofer
doi: https://doi.org/10.1101/441253
Carolee Winstein
Division of Biokinesiology and Physical Therapy, Herman Ostrow School of Dentistry and Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA (CW)
PT, PhDBokkyu Kim
PT, PhD
Sujin Kim
PT, PhD
Clarisa Martinez
PT, DPT, MS
Posted October 11, 2018.
Dosage Matters: A Randomized Controlled Trial of Rehabilitation Dose in the Chronic Phase after Stroke
Carolee Winstein, Bokkyu Kim, Sujin Kim, Clarisa Martinez, Nicolas Schweighofer
bioRxiv 441253; doi: https://doi.org/10.1101/441253
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29129)
- Biophysics (14936)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60814)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)